On the treatment effect in clinical trials with dropout

被引:6
|
作者
Shao, J [1 ]
Zhong, B
机构
[1] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA
[2] Centocor Inc, Malvern, PA 19355 USA
关键词
causal parameters; dropout pattern; last observation analysis; last observation; carry forward; study end;
D O I
10.1080/10543400500406488
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Patient's dropout often occurs in clinical trials with multiple scheduled visits, which results in a great challenge in the analysis of incomplete data. As the first step, one has to de. ne a relevant treatment effect parameter, which is not straightforward in the presence of dropout. We discuss and compare two different treatment effect parameters that are adopted in most analyses of clinical data: the study-end treatment effect and the last-observed treatment effect. Some related issues, such as the estimability of causal parameters, the dependence of study parameters on the dropout patterns, and the use of the last observation carry forward, are also discussed.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 50 条
  • [41] Treatment Recent Clinical Trials
    Gradman, Alan H.
    Basile, Jan N.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (10) : 770 - 774
  • [42] Treatment fidelity in clinical trials
    Cook, Chad E.
    O'Halloran, Bryan
    Karas, Steve
    Klopper, Mareli
    Young, Jodi L.
    ARCHIVES OF PHYSIOTHERAPY, 2024, 14 (01) : 65 - 69
  • [43] Testing the treatment effect on competing causes of death in oncology clinical trials
    Federico Rotolo
    Stefan Michiels
    BMC Medical Research Methodology, 14
  • [44] Adjustment of treatment effect for covariates in clinical trials: Statistical and regulatory issues
    Tu, DS
    Shalay, K
    Pater, J
    DRUG INFORMATION JOURNAL, 2000, 34 (02): : 511 - 523
  • [45] Consistency of HFrEF treatment effect in underrepresented groups in randomized clinical trials
    Guillaume Baudry
    Luca Monzo
    Mark C. Petrie
    Nicolas Girerd
    Ileana L. Piña
    Alexandre Mebazaa
    Javed Butler
    Leila Abid
    Faiez Zannad
    Harriette G. C. Van Spall
    npj Cardiovascular Health, 1 (1):
  • [46] Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
    Albert, JM
    Gadbury, GL
    Mascha, EJ
    BIOMETRICAL JOURNAL, 2005, 47 (05) : 662 - 673
  • [47] Improving testing and description of treatment effect in clinical trials with survival outcomes
    Yang, Song
    STATISTICS IN MEDICINE, 2019, 38 (04) : 530 - 544
  • [48] Treatment allocation in clinical trials
    Webert, Kathryn E.
    TRANSFUSION, 2007, 47 (12) : 2187 - 2188
  • [49] Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
    Wang, Sue-Jane
    O'Neill, Robert T.
    Hung, H. M. James
    PHARMACEUTICAL STATISTICS, 2007, 6 (03) : 227 - 244
  • [50] Testing Treatment Effect in Randomized Clinical Trials With Possible Nonproportional Hazards
    Callegaro, Andrea
    Spiessens, Bart
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (02): : 204 - 211